Investing.com - GoodRx Holdings Inc. (NASDAQ:GDRX) shares jumped 19% on heavy trading volume Wednesday following news about a potential partnership with TrumpRx and an expanded relationship with ...

Oct 1 (Reuters) - GoodRx (GDRX.O), opens new tab said on Wednesday it has partnered with Kroger's (KR.N), opens new tab healthcare unit to expand its prescription savings services for branded drugs, ...

(Reuters) -GoodRx said on Wednesday it has partnered with Kroger's healthcare unit to expand its prescription savings services for branded drugs, including Novo Nordisk's popular weight-loss drug ...

Like Viagra, Stendra and Levitra, Cialis is highly effective as a treatment for ED. But no medication has a 100 percent success rate, and Cialis is no exception. Even after you take Cialis, you could ...

GoodRx offers compelling value after a ~50% stock decline over the past 12 months, trading at just 6.1x FY25 adjusted EBITDA despite recent execution challenges. A new Novo Nordisk partnership for ...

Shares for Santa Monica-based GoodRx climbed by 37% after announcing a deal to offer significantly discounted Wegovy and Ozempic to self-paying customers. GoodRx helps consumers locate discounted ...

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access manufacturer-sponsored savings at the pharmacy. Discounts will help reduce the ...

Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to patients who pay for the medications with cash. Starting this week, customers ...

GoodRx Holdings Inc (NASDAQ:GDRX) shares are pulling back Tuesday morning, as investors potentially take profits following Monday’s surge. The stock had jumped over 30% Monday after the company ...

GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing, driving a 30% stock surge and validating its business model. Pharma Manufacturer ...

GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...